HIV-1 Efficient Entry in Inner Foreskin Is Mediated by Elevated CCL5/RANTES that Recruits T Cells and Fuels Conjugate Formation with Langerhans Cells
Male circumcision reduces acquisition of HIV-1 by 60%. Hence, the foreskin is an HIV-1 entry portal during sexual transmission. We recently reported that efficient HIV-1 transmission occurs following 1 h of polarized exposure of the inner, but not outer, foreskin to HIV-1-infected cells, but not to cell-free virus. At this early time point, Langerhans cells (LCs) and T-cells within the inner foreskin epidermis are the first cells targeted by the virus. To gain in-depth insight into the molecular mechanisms governing inner foreskin HIV-1 entry, foreskin explants were inoculated with HIV-1-infeceted cells for 4 h. The chemokine/cytokine milieu secreted by the foreskin tissue, and resulting modifications in density and spatial distribution of T-cells and LCs, were then investigated. Our studies show that in the inner foreskin, inoculation with HIV-1-infected cells induces increased CCL5/RANTES (1.63-fold) and decreased CCL20/MIP-3-alpha (0.62-fold) secretion. Elevated CCL5/RANTES mediates recruitment of T-cells from the dermis into the epidermis, which is blocked by a neutralizing CCL5/RANTES Ab. In parallel, HIV-1-infected cells mediate a bi-phasic modification in the spatial distribution of epidermal LCs: attraction to the apical surface at 1 h, followed by migration back towards the basement membrane later on at 4 h, in correlation with reduced CCL20/MIP-3-alpha at this time point. T-cell recruitment fuels the continuous formation of LC-T-cell conjugates, permitting the transfer of HIV-1 captured by LCs. Together, these results reveal that HIV-1 induces a dynamic process of immune cells relocation in the inner foreskin that is associated with specific chemokines secretion, which favors efficient HIV-1 entry at this site.
Vyšlo v časopise:
HIV-1 Efficient Entry in Inner Foreskin Is Mediated by Elevated CCL5/RANTES that Recruits T Cells and Fuels Conjugate Formation with Langerhans Cells. PLoS Pathog 7(6): e32767. doi:10.1371/journal.ppat.1002100
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002100
Souhrn
Male circumcision reduces acquisition of HIV-1 by 60%. Hence, the foreskin is an HIV-1 entry portal during sexual transmission. We recently reported that efficient HIV-1 transmission occurs following 1 h of polarized exposure of the inner, but not outer, foreskin to HIV-1-infected cells, but not to cell-free virus. At this early time point, Langerhans cells (LCs) and T-cells within the inner foreskin epidermis are the first cells targeted by the virus. To gain in-depth insight into the molecular mechanisms governing inner foreskin HIV-1 entry, foreskin explants were inoculated with HIV-1-infeceted cells for 4 h. The chemokine/cytokine milieu secreted by the foreskin tissue, and resulting modifications in density and spatial distribution of T-cells and LCs, were then investigated. Our studies show that in the inner foreskin, inoculation with HIV-1-infected cells induces increased CCL5/RANTES (1.63-fold) and decreased CCL20/MIP-3-alpha (0.62-fold) secretion. Elevated CCL5/RANTES mediates recruitment of T-cells from the dermis into the epidermis, which is blocked by a neutralizing CCL5/RANTES Ab. In parallel, HIV-1-infected cells mediate a bi-phasic modification in the spatial distribution of epidermal LCs: attraction to the apical surface at 1 h, followed by migration back towards the basement membrane later on at 4 h, in correlation with reduced CCL20/MIP-3-alpha at this time point. T-cell recruitment fuels the continuous formation of LC-T-cell conjugates, permitting the transfer of HIV-1 captured by LCs. Together, these results reveal that HIV-1 induces a dynamic process of immune cells relocation in the inner foreskin that is associated with specific chemokines secretion, which favors efficient HIV-1 entry at this site.
Zdroje
1. AuvertBTaljaardDLagardeESobngwi-TambekouJSittaR 2005 Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2 e298
2. BaileyRCMosesSParkerCBAgotKMacleanI 2007 Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369 643 56
3. GrayRHKigoziGSerwaddaDMakumbiFWatyaS 2007 Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369 657 66
4. QuinnTC 2007 Circumcision and HIV transmission. Curr Opin Infect Dis 20 33 8
5. RossHMRomrellLJKayeGI Histology, a text an atlas. Third ed ed, ed. P.A. Coryell 1995 Baltimore Williams & Wilkins 58 93
6. HussainLALehnerT 1995 Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology 85 475 84
7. PattersonBKLandayASiegelJNFlenerZPessisD 2002 Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol 161 867 73
8. McCoombeSGShortRV 2006 Potential HIV-1 target cells in the human penis. Aids 20 1491 5
9. GanorYBomselM 2010 HIV-1 Transmission in the Male Genital Tract. Am J Reprod Immunol In press
10. GanorYZhouZTudorDSchmittAVacher-LavenuMC 2010 Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates. Mucosal Immunol 3 506 22
11. QinQZhengXYWangYYShenHFSunF 2009 Langerhans' cell density and degree of keratinization in foreskins of Chinese preschool boys and adults. Int Urol Nephrol 41 747 53
12. DinhMHMcRavenMDKelleyZPenugondaSHopeTJ 2010 Keratinization of the adult male foreskin and implications for male circumcision. Aids 24 899 906
13. PaskAJMcInnesKJWebbDRShortRV 2008 Topical oestrogen keratinises the human foreskin and may help prevent HIV infection. PLoS ONE 3 e2308
14. DonovalBALandayALMosesSAgotKNdinya-AcholaJO 2006 HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. Am J Clin Pathol 125 386 91
15. HirbodTBaileyRCAgotKMosesSNdinya-AcholaJ 2010 Abundant expression of HIV target cells and C-type lectin receptors in the foreskin tissue of young Kenyan men. Am J Pathol 176 2798 805
16. FischettiLBarrySMHopeTJShattockRJ 2009 HIV-1 infection of human penile explant tissue and protection by candidate microbicides. Aids 23 319 28
17. SoilleuxEJColemanN 2004 Expression of DC-SIGN in human foreskin may facilitate sexual transmission of HIV. J Clin Pathol 57 77 8
18. ValladeauJRavelODezutter-DambuyantCMooreKKleijmeerM 2000 Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12 71 81
19. TurvilleSGCameronPUHandleyALinGPohlmannS 2002 Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol 3 975 83
20. GeijtenbeekTBKwonDSTorensmaRvan VlietSJvan DuijnhovenGC 2000 DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100 587 97
21. FigdorCGvan KooykYAdemaGJ 2002 C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2 77 84
22. de WitteLNabatovAPionMFluitsmaDde JongMA 2007 Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 13 367 71
23. SchallTJBaconKToyKJGoeddelDV 1990 Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347 669 71
24. SchallTJ 1991 Biology of the RANTES/SIS cytokine family. Cytokine 3 165 83
25. HladikFSakchalathornPBallweberLLentzGFialkowM 2007 Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26 257 70
26. MeradMGinhouxFCollinM 2008 Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 8 935 47
27. SalleBBrochardPBourryOManniouiAAndrieuT 2010 Infection of macaques after vaginal exposure to cell-associated simian immunodeficiency virus. J Infect Dis 202 337 44
28. AndersonDJPolitchJANadolskiAMBlaskewiczCDPudneyJ 2010 Targeting Trojan Horse leukocytes for HIV prevention. Aids 24 163 87
29. de NadaiPChenivesseCGiletJPorteHVorngH 2006 CCR5 usage by CCL5 induces a selective leukocyte recruitment in human skin xenografts in vivo. J Invest Dermatol 126 2057 64
30. FahrbachKMBarrySMAndersonMRHopeTJ 2010 Enhanced cellular responses and environmental sampling within inner foreskin explants: implications for the foreskin's role in HIV transmission. Mucosal Immunol 3 410 8
31. Dieu-NosjeanMCMassacrierCHomeyBVanbervlietBPinJJ 2000 Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 192 705 18
32. HaaseAT 2010 Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464 217 23
33. LiQEstesJDSchlievertPMDuanLBrosnahanAJ 2009 Glycerol monolaurate prevents mucosal SIV transmission. Nature 458 1034 8
34. ShenRRichterHEClementsRHNovakLHuffK 2009 Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection. J Virol 83 3258 67
35. HladikFMcElrathMJ 2008 Setting the stage: host invasion by HIV. Nat Rev Immunol 8 447 57
36. PiguetVSteinmanRM 2007 The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol 28 503 10
37. WuLKewalRamaniVN 2006 Dendritic-cell interactions with HIV: infection and viral dissemination. Nat Rev Immunol 6 859 68
38. de JongMAde WitteLOudhoffMJGringhuisSIGallayP 2008 TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. J Clin Invest 118 3440 52
39. FahrbachKMBarrySMAyehunieSLamoreSKlausnerM 2007 Activated CD34-Derived Langerhans Cells Mediate Transinfection with Human Immunodeficiency Virus. J Virol 81 6858 68
40. KawamuraTCohenSSBorrisDLAquilinoEAGlushakovaS 2000 Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J Exp Med 192 1491 500
41. KawamuraTKoyanagiYNakamuraYOgawaYYamashitaA 2008 Significant virus replication in Langerhans cells following application of HIV to abraded skin: relevance to occupational transmission of HIV. J Immunol 180 3297 304
42. PopeMBetjesMGRomaniNHirmandHCameronPU 1994 Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78 389 98
43. SugayaMLoreKKoupRADouekDCBlauveltA 2004 HIV-infected Langerhans cells preferentially transmit virus to proliferating autologous CD4+ memory T cells located within Langerhans cell-T cell clusters. J Immunol 172 2219 24
44. ReeceJCHandleyAJAnsteeEJMorrisonWACroweSM 1998 HIV-1 selection by epidermal dendritic cells during transmission across human skin. J Exp Med 187 1623 31
45. CameronPUFreudenthalPSBarkerJMGezelterSInabaK 1992 Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science 257 383 7
46. LussoP 2006 HIV and the chemokine system: 10 years later. Embo J 25 447 56
47. KuritzkesDR 2009 HIV-1 entry inhibitors: an overview. Curr Opin HIV AIDS 4 82 7
48. BiswasPTambussiGLazzarinA 2007 Access denied? The status of co-receptor inhibition to counter HIV entry. Expert Opin Pharmacother 8 923 33
49. VeazeyRSKetasTJDufourJMoroney-RasmussenTGreenLC 2010 Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor. J Infect Dis 202 739 44
50. LedermanMMVeazeyRSOffordRMosierDEDufourJ 2004 Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 306 485 7
51. LagayeSDerrienMMenuECoitoCTresoldiE 2001 Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection. J Virol 75 4780 91
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 6
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- High Affinity Nanobodies against the VSG Are Potent Trypanolytic Agents that Block Endocytosis
- Structural and Mechanistic Studies of Measles Virus Illuminate Paramyxovirus Entry
- Sporangiospore Size Dimorphism Is Linked to Virulence of
- Uses Host Triacylglycerol to Accumulate Lipid Droplets and Acquires a Dormancy-Like Phenotype in Lipid-Loaded Macrophages